查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1751238

遠距醫療市場規模、佔有率、趨勢分析報告：按類型、地區、細分市場、預測，2025 年至 2030 年

Telecare Market Size, Share & Trends Analysis Report By Type (Activity Monitoring, Remote Medication Management), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

遠距醫療市場的成長與趨勢：

根據 Grand View Research, Inc. 的最新報告，全球遠距醫療市場規模預計到 2030 年將達到 63.4 億美元，2025 年至 2030 年的複合年成長率為 4.79%。

遠距醫療主要服務於社會弱勢群體和老年人，使他們能夠在緊急情況下立即聯繫到相關人員尋求協助。此外，從電話到線上虛擬問診，新技術的不斷發展塑造了現代醫療服務的面貌。因此，技術進步在推動市場成長方面發揮關鍵作用。穿戴式裝置、遠端監控系統和遠端醫療平台等創新技術正在透過實現即時健康監測、虛擬問診和遠端病患管理，徹底改變醫療保健服務。例如，2023年6月，Telecare推出了澳洲獨立的電子處方箋平台RxPad。

這項創新解決方案由臨床醫生設計，服務於臨床醫生，旨在取代傳統的紙處方箋。 RxPad 徹底改變了醫療服務方式，改善了病患體驗，增強了醫生的能力，使所有相關人員的諮詢更加有效率和愉快。這項創新設備提供了市場上最先進的功能。此外，日益成長的老化人口是市場擴張的主要驅動力。隨著老齡化人口的成長，對醫療服務的需求也日益成長，尤其是慢性病管理和老年護理。 Telecare 透過為老年人提供持續的監控和支持，為滿足這項需求提供了可行的解決方案。這使老年患者能夠在獲得及時醫療護理的同時過著獨立的生活。

這些人口結構的變化為遠距照護解決方案創造了一個巨大的市場，這些解決方案可以滿足老年人的獨特需求，並促進老齡化社會的安全、健康和福祉。此外，慢性病的日益普及和對個人化醫療解決方案日益成長的需求，正在推動遠距照護技術的應用。糖尿病、高血壓和心臟病等慢性疾病需要持續的監測和管理，遠端監控解決方案可以有效地促進這一進程。遠距照護可以進行預防性疾病管理、併發症的早期發現和及時干預，從長遠來看可以改善患者的治療效果並降低醫療成本。隨著醫療保健相關人員意識到遠端監控和護理管理解決方案在提供可訪問、經濟高效和以患者為中心的醫療服務方面的變革潛力，預計市場將繼續成長。

遠距醫療市場報告重點

  • 到 2024 年，遠距藥物管理領域將以 50.97% 的最大收益佔有率引領市場。這一成長可以歸因於多種因素，包括人口老化、慢性病患病率上升、老年人遠距照護應用程式的開發以及技術進步。
  • 由於技術進步以及對改善醫療保健管道和結果的需求不斷增加，預計活動監測部門在預測期內將以顯著的複合年成長率成長。
  • 到 2024 年，北美將以 49.13% 的最大收益佔有率佔據遠距醫療市場的主導地位，這歸因於智慧型手機和網路普及率高、個人保持身體健康意識增強以及遠距醫療服務的利用等多種因素。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章遠距醫療市場變數、趨勢和範圍

  • 市場展望
    • 母市場展望
    • 補貼市場前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 遠距醫療：市場分析工具
    • 產業分析-波特五力分析
    • PESTLE分析
  • 遠距醫療市場：醫療系統的成果與機會
  • 遠距醫療市場新興企業和成熟公司的分析
  • 各國監管狀況

4. 2018 年至 2030 年按類型分類的遠距醫療市場細分分析

  • 定義和範圍
  • 2024 年及 2030 年各類型市場佔有率分析
  • 細分儀表板
  • 2018-2030 年全球遠距醫療市場（按類型）
  • 活動監控
  • 遠端藥物管理

5. 2018 年至 2030 年按地區分類的遠距醫療市場細分分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 區域市場概況
  • 2024 年及 2030 年各地區遠距醫療市場佔有率
  • 北美洲
    • 2018-2030年北美遠距醫療市場
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲遠距護理市場，2018-2030
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 亞太遠距護理市場，2018-2030
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 拉丁美洲遠距護理市場，2018-2030
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 2018-2030年中東和非洲遠距醫療市場
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司分類
  • Company Position Analysis
  • Company Evaluation Metrix
  • 公司簡介
    • Teladoc Health, Inc.
    • Abbott Laboratories
    • Johnson and Johnson
    • AstraZeneca PLC
    • F. Hoffmann-La Roche Ltd.
    • Novartis AG
    • NeoRehab
    • Bristol-Myers Squibb Company
    • GlaxoSmithKline plc
    • Merck and Co., Inc.
    • Pfizer, Inc.
    • Sanofi
    • Samsung Electronics Co. Ltd
    • Qualcomm Technologies, Inc.
    • Orange
    • Google（Alphabet）, Inc
    • Allscripts
    • Apple, Inc.
    • AT&T
    • Airstrip Technologies, Inc
Product Code: GVR-4-68039-915-1

Telecare Market Growth & Trends:

The global telecare market size is estimated to reach USD 6.34 billion by 2030, registering a CAGR of 4.79% from 2025 to 2030, according to a new report by Grand View Research, Inc. Telecare provides services mainly to vulnerable and elderly individuals for immediate contact with someone for help in case of any emergency. In addition, the increasing development of new technology, from telephones to online virtual visits, has shaped the face of modern healthcare services. Thus, technological advancements have played a crucial role in driving the market growth. Innovations, such as wearable devices, remote monitoring systems, and telemedicine platforms, have revolutionized healthcare delivery by enabling real-time health monitoring, virtual consultations, and remote patient management. For instance, in June 2023, Telecare introduced RxPad, Australia's standalone platform for electronic prescriptions.

Designed by clinicians for clinicians, this innovative solution aims to replace traditional paper prescriptions. RxPad is poised to revolutionize healthcare delivery, improving patient experiences and empowering doctors, making consultations more efficient and enjoyable for everyone involved. This innovative device offers the most advanced features in the market. Moreover, the growing aging population is a significant factor propelling market expansion. With the growing aging population, the demand for healthcare services increases, particularly for chronic disease management and elderly care. Telecare offers a viable solution to meet these demands by providing continuous monitoring and support for older adults. It enables elderly patients to live independently while ensuring they receive timely medical attention.

This demographic shift is creating a substantial market for telecare solutions that cater to the specific needs of older individuals, promoting safety, health, and well-being in an aging society. Furthermore, the increasing prevalence of chronic diseases and rising demand for personalized healthcare solutions have propelled the adoption of telecare technologies. Chronic conditions, such as diabetes, hypertension, and heart disease, require continuous monitoring and management, which can be effectively facilitated through remote monitoring solutions. Telecare enables proactive disease management, early detection of complications, and timely interventions, leading to improved patient outcomes and reduced healthcare costs in the long run. The market is poised for continued growth as healthcare stakeholders recognize the transformative potential of remote monitoring and care management solutions in delivering accessible, cost-effective, and patient-centered healthcare services.

Telecare Market Report Highlights:

  • The remote medication management segment led the market with the largest revenue share of 50.97% in 2024, attributed to several factors, including the aging population, increased prevalence of chronic diseases, development of elderly telecare apps and technological advancements.
  • The activity monitoring segment is anticipated to grow at the significant CAGR over the forecast period, owing to technological advancements and the increasing demand for improved healthcare access and outcomes.
  • North America dominated the telecare market with the largest revenue share of 49.13% in 2024, attributed to several factors such as the high penetration of smartphones and the internet, growing awareness among individuals to maintain physical health and the use of remote healthcare services.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Telecare Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Aging population and elderly care needs for telecare
      • 3.2.1.2. Technological improvements in AI and ML
      • 3.2.1.3. Advances in wearable health technology
      • 3.2.1.4. Growing shift to home healthcare services
      • 3.2.1.5. Increased focus on chronic disease management
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Privacy and security concerns over patient data
      • 3.2.2.2. Complexity of regulatory compliance
      • 3.2.2.3. Lack of standardization across platforms
      • 3.2.2.4. Limited insurance reimbursement for telecare services
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Leveraging ai, big data, and predictive analytics
      • 3.2.3.2. Collaborations with healthcare providers and insurers
      • 3.2.3.3. Increased focus on mental health and remote counseling
    • 3.2.4. Market challenges analysis
      • 3.2.4.1. Connectivity and infrastructure gaps in rural areas
      • 3.2.4.2. Resistance from healthcare providers and traditional systems
  • 3.3. Telecare: Market Analysis Tools
    • 3.3.1. Industry analysis - Porter's
    • 3.3.2. PESTLE analysis
  • 3.4. Telecare Market: Accomplishments and Opportunities Across the Health System Sectors
  • 3.5. Analysis on Start-ups and Established Companies in Telecare Market
  • 3.6. Regulatory Landscape, By Country
    • 3.6.1. Regulatory overview
    • 3.6.2. Health data privacy and security laws
    • 3.6.3. Telemedicine licensing and reimbursement policies
    • 3.6.4. Government initiatives and support
    • 3.6.5. Emerging trends in regulatory compliance
  • 3.7. Value Chain Analysis
    • 3.7.1. Telecare value chain overview
    • 3.7.2. Key stakeholders and their roles
    • 3.7.3. Technology providers and platforms
    • 3.7.4. Service delivery and interoperability
    • 3.7.5. Distribution and supply chain management
    • 3.7.6. Revenue streams and business models
    • 3.7.7. Challenges in the value chain
  • 3.8. Technology Landscape
    • 3.8.1. Technological advancements driving telecare
    • 3.8.2. Telecare software and applications
    • 3.8.3. Data analytics and artificial intelligence
    • 3.8.4. Wearable devices and IoT integration
    • 3.8.5. Telecommunication infrastructure
  • 3.9. Case Study Analysis
  • 3.10. Funding/Investment Trends Scenario
    • 3.10.1. Venture capital (VC) deal activity
    • 3.10.2. Top 10 digital health VC deals in 2024
    • 3.10.3. Annual equity funding & deals
    • 3.10.4. Quarterly equity funding & deals
    • 3.10.5. Quarter funding & deals by global region
    • 3.10.6. Percent of quarterly deals by global region
    • 3.10.7. Percent of quarterly deals by investor group
    • 3.10.8. Annual average & median deal size
    • 3.10.9. Annual median deal size by global region
    • 3.10.10. Annual median deal size by investor group
    • 3.10.11. Annual mega-round funding & deals
    • 3.10.12. Quarterly funding & deals from mega-rounds (deals worth usd 100 million+)
    • 3.10.13. Quarter mega-round funding & deals by global region
    • 3.10.14. Quarterly mega-round deals by global region
    • 3.10.15. Quarterly mega-rounds as percentage of funding
    • 3.10.16. Quarter top equity deals
    • 3.10.17. Annual percentage of deals by deal stage
    • 3.10.18. Quarter regional deal shares by deal stage
    • 3.10.19. Annual median funding by deal stage
    • 3.10.20. Quarter top seed/angel deals
    • 3.10.21. Quarter top series A deals
    • 3.10.22. Quarter top series B deals
    • 3.10.23. Quarter top series C deals
    • 3.10.24. Quarter top series D deals
    • 3.10.25. Quarter top series E+ deals
  • 3.11. Unicorn Funding Trends in Digital Health
    • 3.11.1. Quarterly new & total unicorns (private companies valued at USD 1 billion+)
    • 3.11.2. Quarter new & total unicorns by global region
    • 3.11.3. Quarterly new unicorns by global region
    • 3.11.4. Quarter top unicorns by valuation
  • 3.12. Exit Trends in Digital Health Market
    • 3.12.1. Annual exits
    • 3.12.2. Quarterly exits
    • 3.12.3. Percent of quarterly exits by global region
    • 3.12.4. Quarter top M&A exits
    • 3.12.5. Quarter top IPOs
  • 3.13. Key Investors Analysis in the Digital Health Landscape
    • 3.13.1. Quarter top investors by company count
    • 3.13.2. Quarter top VCs by company count
    • 3.13.3. Quarter top corporate VCs (CVCs) by company count
  • 3.14. Key Investment Geographic Trends in Digital Health Market
    • 3.14.1. U.S. Trends
      • 3.14.1.1. Annual funding & deals
      • 3.14.1.2. Quarterly funding & deals
      • 3.14.1.3. Annual percentage of deals by deal stage
      • 3.14.1.4. Quarter top equity deals
      • 3.14.1.5. Annual exits
      • 3.14.1.6. Quarterly exists
      • 3.14.1.7. Quarter top investors by company count
    • 3.14.2. Asia Trends
      • 3.14.2.1. Annual funding & deals
      • 3.14.2.2. Quarterly funding & deals
      • 3.14.2.3. Annual percentage of deals by deal stage
      • 3.14.2.4. Quarter top equity deals
      • 3.14.2.5. Annual exits
      • 3.14.2.6. Quarterly exists
      • 3.14.2.7. Quarter top investors by company count
    • 3.14.3. China
    • 3.14.4. Japan
    • 3.14.5. Europe Trends
      • 3.14.5.1. Annual funding & deals
      • 3.14.5.2. Quarterly funding & deals
      • 3.14.5.3. Annual percentage of deals by deal stage
      • 3.14.5.4. Quarter top equity deals
      • 3.14.5.5. Annual exits
      • 3.14.5.6. Quarterly exists
      • 3.14.5.7. Quarter top investors by company count
    • 3.14.6. UK

Chapter 4. Telecare Market Segment Analysis, By Type, 2018-2030 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Type Market Share Analysis, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Telecare Market, by Type, 2018 to 2030
  • 4.5. Activity Monitoring
    • 4.5.1. Activity Monitoring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Remote Medication Management
    • 4.6.1. Remote Medication Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Telecare Market Segment Analysis, By Region, 2018- 2030 (USD Million)

  • 5.1. Regional Market Share Analysis, 2024 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Regional Market Snapshot
  • 5.4. Telecare Market Share by Region, 2024 & 2030:
  • 5.5. North America
    • 5.5.1. North America telecare market, 2018 - 2030 (USD Million)
    • 5.5.2. U.S.
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Regulatory Scenario
      • 5.5.2.3. Competitive Scenario
      • 5.5.2.4. U.S. telecare market, 2018 - 2030 (USD Million)
    • 5.5.3. Canada
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Regulatory Scenario
      • 5.5.3.3. Competitive Scenario
      • 5.5.3.4. Canada telecare market, 2018 - 2030 (USD Million)
    • 5.5.4. Mexico
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Regulatory Scenario
      • 5.5.4.3. Competitive Scenario
      • 5.5.4.4. Mexico telecare market, 2018 - 2030 (USD Million)
  • 5.6. Europe
    • 5.6.1. Europe telecare market, 2018 - 2030 (USD Million)
    • 5.6.2. UK
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Regulatory Scenario
      • 5.6.2.3. Competitive Scenario
      • 5.6.2.4. UK telecare market, 2018 - 2030 (USD Million)
    • 5.6.3. Germany
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Regulatory Scenario
      • 5.6.3.3. Competitive Scenario
      • 5.6.3.4. Germany telecare market, 2018 - 2030 (USD Million)
    • 5.6.4. France
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Regulatory Scenario
      • 5.6.4.3. Competitive Scenario
      • 5.6.4.4. France telecare market, 2018 - 2030 (USD Million)
    • 5.6.5. Italy
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Regulatory Scenario
      • 5.6.5.3. Competitive Scenario
      • 5.6.5.4. Italy telecare market, 2018 - 2030 (USD Million)
    • 5.6.6. Spain
      • 5.6.6.1. Key Country Dynamics
      • 5.6.6.2. Regulatory Scenario
      • 5.6.6.3. Competitive Scenario
      • 5.6.6.4. Spain telecare market, 2018 - 2030 (USD Million)
    • 5.6.7. Norway
      • 5.6.7.1. Key Country Dynamics
      • 5.6.7.2. Regulatory Scenario
      • 5.6.7.3. Competitive Scenario
      • 5.6.7.4. Norway telecare market, 2018 - 2030 (USD Million)
    • 5.6.8. Sweden
      • 5.6.8.1. Key Country Dynamics
      • 5.6.8.2. Regulatory Scenario
      • 5.6.8.3. Competitive Scenario
      • 5.6.8.4. Sweden telecare market, 2018 - 2030 (USD Million)
    • 5.6.9. Denmark
      • 5.6.9.1. Key Country Dynamics
      • 5.6.9.2. Regulatory Scenario
      • 5.6.9.3. Competitive Scenario
      • 5.6.9.4. Denmark telecare market, 2018 - 2030 (USD Million)
  • 5.7. Asia Pacific
    • 5.7.1. Asia Pacific telecare market, 2018 - 2030 (USD Million)
    • 5.7.2. Japan
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Regulatory Scenario
      • 5.7.2.3. Competitive Scenario
      • 5.7.2.4. Japan telecare market, 2018 - 2030 (USD Million)
    • 5.7.3. China
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Regulatory Scenario
      • 5.7.3.3. Competitive Scenario
      • 5.7.3.4. China telecare market, 2018 - 2030 (USD Million)
    • 5.7.4. India
      • 5.7.4.1. Key Country Dynamics
      • 5.7.4.2. Regulatory Scenario
      • 5.7.4.3. Competitive Scenario
      • 5.7.4.4. India telecare market, 2018 - 2030 (USD Million)
    • 5.7.5. Australia
      • 5.7.5.1. Key Country Dynamics
      • 5.7.5.2. Regulatory Scenario
      • 5.7.5.3. Competitive Scenario
      • 5.7.5.4. Australia telecare market, 2018 - 2030 (USD Million)
    • 5.7.6. South Korea
      • 5.7.6.1. Key Country Dynamics
      • 5.7.6.2. Regulatory Scenario
      • 5.7.6.3. Competitive Scenario
      • 5.7.6.4. South Korea telecare market, 2018 - 2030 (USD Million)
    • 5.7.7. Thailand
      • 5.7.7.1. Key Country Dynamics
      • 5.7.7.2. Regulatory Scenario
      • 5.7.7.3. Competitive Scenario
      • 5.7.7.4. Thailand telecare market, 2018 - 2030 (USD Million)
  • 5.8. Latin America
    • 5.8.1. Latin America telecare market, 2018 - 2030 (USD Million)
    • 5.8.2. Brazil
      • 5.8.2.1. Key Country Dynamics
      • 5.8.2.2. Regulatory Scenario
      • 5.8.2.3. Competitive Scenario
      • 5.8.2.4. Brazil telecare market, 2018 - 2030 (USD Million)
    • 5.8.3. Argentina
      • 5.8.3.1. Key Country Dynamics
      • 5.8.3.2. Regulatory Scenario
      • 5.8.3.3. Competitive Scenario
      • 5.8.3.4. Argentina telecare market, 2018 - 2030 (USD Million)
  • 5.9. MEA
    • 5.9.1. MEA telecare market, 2018 - 2030 (USD Million)
    • 5.9.2. South Africa
      • 5.9.2.1. Key Country Dynamics
      • 5.9.2.2. Regulatory Scenario
      • 5.9.2.3. Competitive Scenario
      • 5.9.2.4. South Africa telecare market, 2018 - 2030 (USD Million)
    • 5.9.3. Saudi Arabia
      • 5.9.3.1. Key Country Dynamics
      • 5.9.3.2. Regulatory Scenario
      • 5.9.3.3. Competitive Scenario
      • 5.9.3.4. Saudi Arabia telecare market, 2018 - 2030 (USD Million)
    • 5.9.4. UAE
      • 5.9.4.1. Key Country Dynamics
      • 5.9.4.2. Regulatory Scenario
      • 5.9.4.3. Competitive Scenario
      • 5.9.4.4. UAE telecare market, 2018 - 2030 (USD Million)
    • 5.9.5. Kuwait
      • 5.9.5.1. Key Country Dynamics
      • 5.9.5.2. Regulatory Scenario
      • 5.9.5.3. Competitive Scenario
      • 5.9.5.4. Kuwait telecare market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company Categorization
  • 6.3. Company Position Analysis
  • 6.4. Company Evaluation Metrix
  • 6.5. Company Profiles
    • 6.5.1. Teladoc Health, Inc.
      • 6.5.1.1. Company overview
      • 6.5.1.2. Financial performance
      • 6.5.1.3. Product benchmarking
      • 6.5.1.4. Strategic initiatives
    • 6.5.2. Abbott Laboratories
      • 6.5.2.1. Company overview
      • 6.5.2.2. Financial performance
      • 6.5.2.3. Product benchmarking
      • 6.5.2.4. Strategic initiatives
    • 6.5.3. Johnson and Johnson
      • 6.5.3.1. Company overview
      • 6.5.3.2. Financial performance
      • 6.5.3.3. Product benchmarking
      • 6.5.3.4. Strategic initiatives
    • 6.5.4. AstraZeneca PLC
      • 6.5.4.1. Company overview
      • 6.5.4.2. Financial performance
      • 6.5.4.3. Product benchmarking
      • 6.5.4.4. Strategic initiatives
    • 6.5.5. F. Hoffmann-La Roche Ltd.
      • 6.5.5.1. Company overview
      • 6.5.5.2. Financial performance
      • 6.5.5.3. Product benchmarking
      • 6.5.5.4. Strategic initiatives
    • 6.5.6. Novartis AG
      • 6.5.6.1. Company overview
      • 6.5.6.2. Financial performance
      • 6.5.6.3. Product benchmarking
      • 6.5.6.4. Strategic initiatives
    • 6.5.7. NeoRehab
      • 6.5.7.1. Company overview
      • 6.5.7.2. Financial performance
      • 6.5.7.3. Product benchmarking
      • 6.5.7.4. Strategic initiatives
    • 6.5.8. Bristol-Myers Squibb Company
      • 6.5.8.1. Company overview
      • 6.5.8.2. Financial performance
      • 6.5.8.3. Product benchmarking
      • 6.5.8.4. Strategic initiatives
    • 6.5.9. GlaxoSmithKline plc
      • 6.5.9.1. Company overview
      • 6.5.9.2. Financial performance
      • 6.5.9.3. Product benchmarking
      • 6.5.9.4. Strategic initiatives
    • 6.5.10. Merck and Co., Inc.
      • 6.5.10.1. Company overview
      • 6.5.10.2. Financial performance
      • 6.5.10.3. Product benchmarking
      • 6.5.10.4. Strategic initiatives
    • 6.5.11. Pfizer, Inc.
      • 6.5.11.1. Company overview
      • 6.5.11.2. Financial performance
      • 6.5.11.3. Product benchmarking
      • 6.5.11.4. Strategic initiatives
    • 6.5.12. Sanofi
      • 6.5.12.1. Company overview
      • 6.5.12.2. Financial performance
      • 6.5.12.3. Product benchmarking
      • 6.5.12.4. Strategic initiatives
    • 6.5.13. Samsung Electronics Co. Ltd
      • 6.5.13.1. Company overview
      • 6.5.13.2. Financial performance
      • 6.5.13.3. Product benchmarking
      • 6.5.13.4. Strategic initiatives
    • 6.5.14. Qualcomm Technologies, Inc.
      • 6.5.14.1. Company overview
      • 6.5.14.2. Financial performance
      • 6.5.14.3. Product benchmarking
      • 6.5.14.4. Strategic initiatives
    • 6.5.15. Orange
      • 6.5.15.1. Company overview
      • 6.5.15.2. Financial performance
      • 6.5.15.3. Product benchmarking
      • 6.5.15.4. Strategic initiatives
    • 6.5.16. Google (Alphabet), Inc
      • 6.5.16.1. Company overview
      • 6.5.16.2. Financial performance
      • 6.5.16.3. Product benchmarking
      • 6.5.16.4. Strategic initiatives
    • 6.5.17. Allscripts
      • 6.5.17.1. Company overview
      • 6.5.17.2. Financial performance
      • 6.5.17.3. Product benchmarking
      • 6.5.17.4. Strategic initiatives
    • 6.5.18. Apple, Inc.
      • 6.5.18.1. Company overview
      • 6.5.18.2. Financial performance
      • 6.5.18.3. Product benchmarking
      • 6.5.18.4. Strategic initiatives
    • 6.5.19. AT&T
      • 6.5.19.1. Company overview
      • 6.5.19.2. Financial performance
      • 6.5.19.3. Product benchmarking
      • 6.5.19.4. Strategic initiatives
    • 6.5.20. Airstrip Technologies, Inc
      • 6.5.20.1. Company overview
      • 6.5.20.2. Financial performance
      • 6.5.20.3. Product benchmarking
      • 6.5.20.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global telecare market, by type, 2018 - 2030 (USD Million)
  • Table 4 North America telecare market, by country, 2018 - 2030 (USD Million)
  • Table 5 North America telecare market, by type, 2018 - 2030 (USD Million)
  • Table 6 U.S. telecare market, by type, 2018 - 2030 (USD Million)
  • Table 7 Canada telecare market, by type, 2018 - 2030 (USD Million)
  • Table 8 Mexico telecare market, by type, 2018 - 2030 (USD Million)
  • Table 9 Europe telecare market, by country, 2018 - 2030 (USD Million)
  • Table 10 Europe telecare market, by type, 2018 - 2030 (USD Million)
  • Table 11 UK telecare market, by type, 2018 - 2030 (USD Million)
  • Table 12 Germany telecare market, by type, 2018 - 2030 (USD Million)
  • Table 13 France telecare market, by type, 2018 - 2030 (USD Million)
  • Table 14 Italy telecare market, by type, 2018 - 2030 (USD Million)
  • Table 15 Spain telecare market, by type, 2018 - 2030 (USD Million)
  • Table 16 Norway telecare market, by type, 2018 - 2030 (USD Million)
  • Table 17 Denmark telecare market, by type, 2018 - 2030 (USD Million)
  • Table 18 Sweden telecare market, by type, 2018 - 2030 (USD Million)
  • Table 19 Asia Pacific telecare market, by country, 2018 - 2030 (USD Million)
  • Table 20 Asia Pacific telecare market, by type, 2018 - 2030 (USD Million)
  • Table 21 Japan telecare market, by type, 2018 - 2030 (USD Million)
  • Table 22 China telecare market, by type, 2018 - 2030 (USD Million)
  • Table 23 India telecare market, by type, 2018 - 2030 (USD Million)
  • Table 24 Australia telecare market, by type, 2018 - 2030 (USD Million)
  • Table 25 South Korea telecare market, by type, 2018 - 2030 (USD Million)
  • Table 26 Thailand telecare market, by type, 2018 - 2030 (USD Million)
  • Table 27 Latin America telecare market, by country, 2018 - 2030 (USD Million)
  • Table 28 Latin America telecare market, by type, 2018 - 2030 (USD Million)
  • Table 29 Brazil telecare market, by type, 2018 - 2030 (USD Million)
  • Table 30 Argentina telecare market, by type, 2018 - 2030 (USD Million)
  • Table 31 Middle East & Africa telecare market, by country, 2018 - 2030 (USD Million)
  • Table 32 Middle East & Africa telecare market, by type, 2018 - 2030 (USD Million)
  • Table 33 South Africa telecare market, by type, 2018 - 2030 (USD Million)
  • Table 34 Saudi Arabia telecare market, by type, 2018 - 2030 (USD Million)
  • Table 35 UAE telecare market, by type, 2018 - 2030 (USD Million)
  • Table 36 Kuwait telecare market, by type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Telecare market: outlook
  • Fig. 8 Telecare competitive insights
  • Fig. 9 Ancillary market outlook
  • Fig. 10 Telecare market driver impact
  • Fig. 11 Telecare market restraint impact
  • Fig. 12 Porter's Analysis
  • Fig. 13 PESTLE Analysis
  • Fig. 14 Telecare market: Type movement analysis
  • Fig. 15 Telecare market: Type outlook and key takeaways
  • Fig. 16 Activity Monitoring market estimates and forecast, 2018 - 2030
  • Fig. 17 Remote Medication Management market estimates and forecast, 2018 - 2030
  • Fig. 18 Global telecare market: Regional movement analysis
  • Fig. 19 Global telecare market: Regional outlook and key takeaways
  • Fig. 20 North America telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Key country dynamics
  • Fig. 22 U.S. telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Key country dynamics
  • Fig. 24 Canada telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Key country dynamics
  • Fig. 26 Mexico telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Europe telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Key country dynamics
  • Fig. 29 UK telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Key country dynamics
  • Fig. 31 Germany telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Key country dynamics
  • Fig. 33 Spain telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Key country dynamics
  • Fig. 35 France telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Key country dynamics
  • Fig. 37 Italy telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Key country dynamics
  • Fig. 39 Norway telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 Denmark telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 Sweden telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Japan telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 China telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 India telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Australia telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 South Korea telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Thailand telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Latin America telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Brazil telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Argentina telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 MEA telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 South Africa telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Saudi Arabia telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 UAE telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Kuwait telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key company categorization
  • Fig. 72 Heat map analysis, 2024